Sedative, Hypnotic & Anxiolytic Addiction Treatment in Boca Raton, FL
Still Detox provides medically supervised sedative addiction treatment in Boca Raton, Florida. Our Medical Director manages withdrawal from all sedative, hypnotic, and anxiolytic drug classes — including benzodiazepines, Z-drugs (Ambien, Lunesta), barbiturates, and prescription sleep aids — using CIWA-guided diazepam substitution taper in a private, 14-bed setting adjacent to Boca Regional Hospital. Sedative withdrawal can be fatal without medical supervision. Call now for a same-day assessment.
Verify Your Insurance
Free & confidential — takes about 60 seconds
Joint Commission Accredited
Florida DCF Licensed
LegitScript Certified
Psychology Today VerifiedWhat Is Sedative Addiction?
Sedative, hypnotic, or anxiolytic use disorder is the DSM-5-TR diagnosis for addiction to central nervous system depressant medications that act on the GABA-A receptor complex. This drug class includes benzodiazepines, Z-drugs, barbiturates, prescription sleep aids, GHB, and some muscle relaxants. Most share a common neurological mechanism (GHB is the main exception, acting mainly on GABA-B receptors): they enhance GABA-A receptor activity, reducing neuronal excitability throughout the CNS. With chronic use, the GABA system downregulates — and when the drug is removed, the rebound neurological hyperexcitability can produce seizures, hallucinations, and cardiovascular instability.
Sedative addiction is distinct from other drug classes precisely because of this withdrawal danger. Unlike opioid withdrawal — which is extremely uncomfortable but rarely directly fatal in healthy adults — sedative withdrawal can kill. The same GABA-A mechanism that makes these drugs effective for anxiety, insomnia, and seizures makes abrupt discontinuation after physical dependence a medical emergency. Still Detox treats the full sedative drug class with physician-supervised tapers, using diazepam substitution for benzodiazepines and Z-drugs and phenobarbital for barbiturates. For benzo-specific content, see our dedicated benzodiazepine addiction treatment page.
Why Sedative Withdrawal Requires Medical Supervision
All drugs in the sedative, hypnotic, and anxiolytic class act on GABA-A receptors — the brain's primary inhibitory system. With chronic use, receptor sensitivity decreases and receptor density changes as the brain compensates for continuous pharmacological inhibition. When sedatives are abruptly removed, the result is a neurological rebound into intense excitability: the nervous system, accustomed to artificial suppression, fires without restraint. The clinical result can be grand mal seizures, hallucinations, delirium, and cardiovascular instability.
This is why the FDA required the boxed warning on all benzodiazepines to be updated in 2020 to cover misuse, addiction, dependence and withdrawal, and why clinical guidelines consistently identify sedative withdrawal as one of the most medically dangerous of all withdrawal syndromes. The risk applies to the full sedative class — not just benzodiazepines. Z-drugs such as zolpidem (Ambien) bind to the same GABA-A receptor and can cause withdrawal seizures upon abrupt discontinuation, yet are widely perceived as safer because they are marketed differently.
At Still Detox, every sedative client receives a CIWA (Clinical Institute Withdrawal Assessment) assessment at admission to quantify withdrawal severity. The taper protocol — typically using diazepam (Valium) as a substitution agent for its long half-life and clinical controllability — is individualized to the specific sedative, dose, duration of use, and the client's medical history. Vital signs and CIWA scores are monitored throughout the acute taper window.
Why Choose Still Detox for Sedative Addiction Treatment in Florida
Sedative withdrawal is medically serious and requires physician-level clinical infrastructure. Still Detox provides the CIWA-guided taper management, hospital-adjacent setting, and dual diagnosis care that the sedative population needs.
CIWA-Guided Diazepam Taper
Every sedative client receives formal CIWA assessment at admission and throughout the taper window. Diazepam substitution — using Valium's long half-life for a smoother, more controllable taper curve — is the standard for benzodiazepines and Z-drugs at Still Detox, and barbiturate dependence is managed with phenobarbital.
On a Hospital Campus
Located on the University Hospital campus, adjacent to Boca Regional Hospital. Emergency neurological and cardiovascular services are immediately accessible for any client whose sedative withdrawal escalates to seizure or cardiovascular instability during the taper window.
Private, 14-Bed Setting
Private rooms, professional catering, and a calm setting designed to minimize the anxiety rebound and sensory hypersensitivity that characterize sedative withdrawal — managed without the chaos of a hospital ward or the isolation of home taper attempts.
Dual Diagnosis: Treating the Underlying Condition
Sedatives are prescribed for anxiety, insomnia, PTSD, and muscle spasm. Still Detox treats the underlying condition concurrently — using non-sedative evidence-based alternatives in the residential program so stopping the sedative does not mean returning to unmanaged anxiety or sleeplessness.
Direct Step Into Residential
Sedative detox flows directly into inpatient residential treatment on the same campus. The insomnia, anxiety disorder, or PTSD driving sedative use is addressed in the therapeutic program that begins where detox ends — same team, no disruption.
Fully Bilingual Care
Every team member is fluent in English and Spanish. Service animals (dogs and cats) are welcome. Sedative addiction treatment is available to all adults regardless of language or companion animal status.
What Patients Say About Treatment at Still Detox
People come to Still Detox when a sleeping pill or anxiety medication has become something they cannot stop. Here is what they say about the care and the recovery they found.
Sedatives We Treat and the Withdrawal Timeline
The sedative, hypnotic, and anxiolytic class covers multiple drug subgroups that share GABA-A receptor activity but differ in potency, half-life, and clinical withdrawal profile. The timeline and approach differ by subgroup — which is why CIWA assessment at admission is essential before any taper begins.
Benzodiazepines range from short-acting (Xanax, Ativan: withdrawal typically begins 1 to 2 days after the last dose and lasts 2 to 4 weeks or longer) to long-acting (Valium, Klonopin: withdrawal typically begins 2 to 7 days after the last dose and lasts 2 to 8 weeks or longer). All carry seizure risk during withdrawal. A gradual, physician-supervised taper is the standard, and switching to a longer-acting benzodiazepine such as diazepam is one option. See our dedicated benzodiazepine addiction treatment page for full drug-by-drug detail and our Ativan treatment page for lorazepam specifically.
Zolpidem (Ambien), eszopiclone (Lunesta), and zaleplon (Sonata) are prescribed and perceived as safer non-benzo sleep aids — but they bind selectively to GABA-A receptor subunits and can produce physical dependence and withdrawal seizures, as benzodiazepines can. In Ambien clinical trials, withdrawal symptoms appeared within 48 hours of the last dose; zolpidem has a short half-life of about 2.5 hours. Abrupt discontinuation after nightly use for weeks can produce rebound insomnia, anxiety, tremors, sweating, and seizures.
Phenobarbital, butalbital (Fioricet/Fiorinal), and other barbiturates act on GABA-A receptors with a narrower margin between a treating dose and a lethal dose than benzodiazepines, and barbiturate withdrawal can cause seizures, delirium, and death. Still Detox manages barbiturate detox with phenobarbital substitution taper and heightened medical monitoring. See our dedicated barbiturates addiction treatment page for full clinical detail.
Carisoprodol (Soma) is broken down into meprobamate, a controlled sedative that can also cause dependence, and stopping carisoprodol after long use can cause tremors, hallucinations, and psychosis. GHB and gamma-butyrolactone produce GABA-B agonist dependence with severe, rapid-onset withdrawal. Each requires individual clinical assessment to determine the appropriate taper approach.
Sedatives We Treat at Still Detox
Every sedative taper protocol at Still Detox is individualized to the specific drug, dose, duration of use, and clinical history. All sedatives in this class carry medically serious withdrawal risk and require physician-supervised discontinuation.
Benzodiazepines and Z-Drugs Physician-supervised taper
Benzodiazepines and Z-drugs (non-benzo sleep aids) share GABA-A receptor activity and the same withdrawal seizure risk. CIWA-guided diazepam substitution taper is the protocol for all drugs in this group.
Barbiturates and Other Sedatives Physician-supervised taper
Barbiturate withdrawal can cause seizures, delirium, and death. Phenobarbital substitution taper is the protocol. Other sedatives in this group are assessed individually for appropriate taper approach.
What to Expect During Sedative Detox at Still Detox
Knowing what to expect removes one of the biggest barriers to making the call. Here is how sedative addiction treatment works from first contact through residential care.
Confidential Call and Insurance Verification
Admissions gathers your specific sedative, current dose, duration of use, and co-occurring conditions (anxiety, insomnia, PTSD). PPO benefits verified before you commit. Travel coordinated before arrival.
Pre-Admission Clinical Assessment
A call within three days covers your full medication and psychiatric history — so the individualized taper schedule is ready on day one and the Medical Director evaluation begins with a complete clinical picture.
Arrival and CIWA Assessment
A nurse and behavioral health tech handle intake together. CIWA assessment begins immediately to quantify withdrawal severity. Diazepam substitution and comfort medications are available from the first hours of admission to prevent acute withdrawal from advancing unchecked.
Medical Director Taper Protocol
Within 24 hours the Medical Director establishes your individualized diazepam substitution taper schedule — calibrated to your specific sedative, dose, and clinical history. CIWA scores drive taper adjustments daily throughout the acute window.
CIWA-Monitored Sedative Taper
Vital signs and CIWA assessments guide medication adjustments throughout. Comfort medications address anxiety, insomnia, elevated blood pressure, and nausea. Typical detox stay is 7 to 10 days, up to 14 days for complex cases such as high-dose, long-duration dependence or barbiturate dependence. Fully tapering off a sedative after long-term use often takes weeks to months.
Seamless Step Into Residential Treatment
After clinical stability is established, you step directly into residential treatment on the same campus. The insomnia, anxiety disorder, or PTSD driving sedative use is addressed using non-sedative evidence-based alternatives — same team, no disruption.
Signs and Symptoms of Sedative Addiction
The DSM-5 classifies sedative addiction as sedative, hypnotic, or anxiolytic use disorder using 11 diagnostic criteria. Any 2 or more in a 12-month period constitutes a diagnosis. Mild is 2 to 3; moderate is 4 to 5; severe is 6 or more.
Using More Than Intended
Taking sedatives in larger doses or more frequently than prescribed or planned. Common in individuals whose prescribed dose no longer controls anxiety or insomnia, driving incremental escalation that crosses into physical dependence.
Failed Attempts to Stop
A persistent desire to reduce or stop combined with repeated unsuccessful attempts. The emergence of withdrawal symptoms — anxiety, insomnia, tremors — within hours to days of dose reduction makes self-discontinuation feel neurologically impossible and physically dangerous.
Excessive Time Spent on Sedatives
Significant time obtaining sedatives, taking them, or managing their effects — including filling prescriptions early, visiting multiple prescribers, or structuring daily activities around dosing schedules to avoid the onset of withdrawal.
Cravings
A strong urge to use sedatives, frequently driven by the onset or anticipation of withdrawal symptoms rather than the pursuit of euphoria. In sedative dependence, craving is the nervous system signaling that GABA receptor function is destabilizing.
Failure to Meet Obligations
Sedation, cognitive blunting, anterograde amnesia, and impaired coordination associated with regular sedative use progressively eroding work performance, family responsibilities, and daily functional capacity.
Continued Use Despite Relationship Harm
Persisting with sedative use despite conflict with family or partners. Emotional withdrawal, memory impairment, and behavioral changes from chronic sedative use are common interpersonal stressors that escalate with disorder severity.
Abandoning Important Activities
Giving up hobbies, social engagement, or valued activities in order to use sedatives or to avoid situations where a dose might be missed and withdrawal triggered. Social withdrawal progressively deepens as the disorder advances.
Use in Hazardous Situations
Using sedatives while driving, combining them with alcohol or opioids (dramatically increasing respiratory depression and overdose risk), or using at doses that produce blackouts. The FDA black box warning on benzodiazepines specifically flags the risk of death when combined with opioids.
Continued Use Despite Known Health Consequences
Persisting despite awareness of cognitive impairment, memory loss, increased fall risk, paradoxical anxiety, depression, respiratory depression, or the documented long-term neurological effects of chronic high-dose sedative use.
Tolerance
Requiring significantly higher sedative doses to achieve the same anxiolytic, sedative, or hypnotic effect, or finding that the prescribed dose no longer provides adequate relief. Tolerance is a direct marker of GABA-A receptor downregulation and advancing physical dependence.
Withdrawal Symptoms
Experiencing rebound anxiety, insomnia, tremors, sweating, elevated heart rate, nausea, sensory hypersensitivity, or seizures when sedatives are delayed or stopped. The presence of withdrawal symptoms is the clearest indicator that medically supervised taper is required — abrupt discontinuation at this point carries seizure and mortality risk.
DSM-5 sedative, hypnotic, or anxiolytic use disorder criteria. If sedatives have become difficult to stop — or if stopping has produced anxiety, tremors, or worse — call now. Do not attempt abrupt discontinuation.
Talk to Admissions ConfidentiallyLiving Proof: Alumni in Recovery From Sedative Addiction
These are real before-and-after moments from people who completed treatment at Still Detox and built a life that no longer depends on a sleeping pill or anxiety medication to function.
Why Stopping Sedatives Without Medical Supervision Is Potentially Fatal
Withdrawal Seizures Can Occur Even at Therapeutic Doses
Sedative withdrawal seizures are documented in individuals using benzodiazepines and Z-drugs at therapeutic doses for extended periods. The risk is higher when a sedative is stopped abruptly or the dose is cut too quickly. Seizure risk cannot be reliably self-assessed without clinical evaluation — the appropriate taper rate requires physician determination.
Rebound Anxiety and Insomnia Exceed Pre-Treatment Baseline
Rebound anxiety and insomnia during sedative withdrawal can surpass the symptoms that originally led to the prescription. The nervous system, accustomed to GABA-A suppression, rebounds into hyperexcitability.
Stopping the Sedative Does Not Address the Underlying Condition
Sedatives are prescribed for anxiety, insomnia, PTSD, muscle spasm, and seizure disorders. Stopping the sedative without treating the underlying condition means those symptoms return in full force during the withdrawal window — at precisely the moment the nervous system is most vulnerable. Dual diagnosis treatment is the clinical center of sedative recovery.
Insurance and Payment for Sedative Addiction Treatment
Still Detox is an out-of-network provider for most insurance plans. Many clients with PPO plans that carry out-of-network benefits apply that coverage toward sedative detox and residential treatment. Our admissions team verifies your specific benefits at no cost and with no obligation before admission.
We confirm what your plan covers, walk through any out-of-pocket responsibility, and explain flexible payment options including monthly payment plans and promissory arrangements. Medically necessary sedative detox should never be delayed because of cost.
- ✓Out-of-network PPO benefitsWe work with most major PPO carriers for sedative detox and residential care.
- ✓Real-time benefits verificationConfirmed before admission, at no cost and no obligation.
- ✓Flexible monthly payment plansPromissory arrangements available for qualifying clients.
- ✓Travel and transportation supportCoordinated for qualifying clients nationwide.
- ✓Secure payment processingBank transfer or card accepted.
Don't see your plan? Call us. Our specialists work with many coverage scenarios and will give you an honest answer about what is covered.
A Calm Environment for Sedative Recovery in Boca Raton
Sedative withdrawal produces intense anxiety and sensory hypersensitivity. Our facility is structured, calm, and clinically equipped for the nervous system recalibration that sedative recovery demands.
Specialized Care for Complex Sedative Addiction Cases
Anxiety Disorders and Sedative Dependence
Sedatives are most commonly prescribed for anxiety. Still Detox treats both the physical sedative dependence and the underlying anxiety disorder concurrently — using non-sedative anxiety management strategies so that stopping the sedative does not mean returning to unmanaged anxiety with no clinical alternative.
Insomnia and Sleeping Pill Dependence
Sleeping pills including Ambien, Lunesta, and benzodiazepine sleep aids can produce physical dependence with nightly use, and the risk grows the longer they are taken. Still Detox manages Z-drug and sedative taper alongside evidence-based non-pharmacological insomnia treatment — cognitive behavioral therapy for insomnia (CBT-I) — so that stopping the sleeping pill does not mean returning to sleeplessness.
High-Dose and Long-Duration Sedative Dependence
Extended high-dose sedative use requires a longer, more gradual taper than short-term lower-dose dependence. Still Detox has experience managing complex taper protocols for clients who have been on sedatives for years at high doses — including cases combining benzos with Z-drugs or muscle relaxants — that require clinical precision beyond standard detox protocols.
Sedative Addiction Treatment FAQ
What is sedative, hypnotic, or anxiolytic use disorder?
Can you become addicted to sleeping pills like Ambien?
How dangerous is sedative withdrawal?
What medications are used during sedative detox?
What is the difference between benzos and Z-drugs like Ambien?
Does insurance cover sedative addiction treatment at Still Detox?
What happens after sedative detox at Still Detox?
Begin Sedative Addiction Treatment at Still Detox
Sedative withdrawal is a medical emergency waiting to happen without the right clinical support. Our CIWA-guided taper protocols, hospital-adjacent setting, and 24-hour nursing team exist precisely for this population. Same-day assessments are available now. The residential care that addresses what the sedative was treating begins immediately after stabilization.
Still Detox · Sedative Addiction Treatment · Boca Raton, FL
On the University Hospital campus, adjacent to Boca Regional Hospital
We're here 24/7. Speak with admissions, confidentially and with no obligation.
✆ Call (561) 556-2677
Medically reviewed by
Dr. Gladys Martinez, DO
Medical Director, Still Detox
Dr. Gladys Martinez, DO, is the Medical Director at Still Detox and a licensed osteopathic physician in Florida (license OS7477). Dr. Martinez evaluates every client in person within 24 hours of admission and oversees detox medication tapers. Read Dr. Gladys Martinez’s full bio.